Sagimet Biosciences (SGMT) Net Equity Issued and Repurchased (2024)

Sagimet Biosciences' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $105.8 million for Q1 2024.

• In Q1 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $105.8 million; the TTM figure through Dec 2024 stood at $105.8 million (changed N/A YoY), while the FY2024 annual figure was $105.8 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q1 2024 stood at $105.8 million.
• The five-year high for Net Equity Issued and Repurchased was $105.8 million in Q1 2024, with the low at $105.8 million in Q1 2024.